PRURITIS
Clinical trials for PRURITIS explained in plain language.
Never miss a new study
Get alerted when new PRURITIS trials appear
Sign up with your email to follow new studies for PRURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic hives sufferers: drug trial shows promise
Symptom relief CompletedThis study tested an experimental drug called povorcitinib in 136 adults with chronic spontaneous urticaria (long-term hives) that standard antihistamines couldn't control. Participants received either the drug or a placebo for 12 weeks. The main goal was to see if the drug reduc…
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 17, 2026 08:54 UTC
-
New drug aims to calm relentless itch of skin disease
Symptom relief CompletedThis study tested an experimental drug called KPL-716 (vixarelimab) to see if it can reduce itching in people with prurigo nodularis, a skin condition that causes hard, itchy bumps. About 240 adults with moderate to severe itching took part. The study compared the drug to a place…
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:52 UTC